PEPTIDE COMPOSITION Russian patent published in 2021 - IPC A61K47/42 A61K9/08 A61L27/00 

Abstract RU 2740185 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to a stable peptide composition comprising: a self-assembling peptide; buffer agent containing at least one substance selected from a group, consisting of histidine, thiamine nitrate, pyridine, bis-tris, ethylenediamine and/or N-methylmorpholine; and water, wherein stable peptide composition has pH from 4.5 to 6.6; wherein the total charge of the amino acid residues contained in the self-assembling peptide is between more than 0 and +3 or less in the stable peptide composition; wherein the C-terminal of the self-assembling peptide includes an amide group; wherein the amino acid at the C-terminal of the self-assembling peptide contains a basic amino acid; wherein the self-assembling peptide is formed from the following amino acid sequence: a1b1c1b2a2b3db4a3b5c2b6a4, where each residue a1–a4 is a basic amino acid residue, each residue b1–b6 is an uncharged polar amino acid residue and/or a hydrophobic amino acid residue, provided that at least five of them are a hydrophobic amino acid residue, each residue c1–c2 is an acidic amino acid residue and d is a hydrophobic amino acid residue; wherein the self-assembling peptide contains a peptide formed by the amino acid sequence: n-RLDLRLALRLDLR-c (SEQ ID NO:1), n-RLDLRLSLRLDLR-c (SEQ ID NO:2), n-RLALRLDLRLDLR-c (SEQ ID NO:3), n-KRLDLNLRLDLRK-c (SEQ ID NO:4), and also relates to a method of producing a stable peptide composition.

EFFECT: group of inventions provides a stable and transparent peptide composition.

4 cl, 4 tbl, 14 ex

Similar patents RU2740185C2

Title Year Author Number
INSULINOTROPIC PEPTIDE DERIVATIVE WITH MODIFIED N-TERMINAL CHARGE 2014
  • Jung Sung Youb
  • Hwang Sang Youn
  • Choi In Young
  • Park Sung Hee
  • Kwon Se Chang
RU2673179C2
ANTIBIOTIC PEPTIDES 2008
  • Khoffmann Ral'F
  • Chikhal' Patritsija
RU2472805C2
INDIVIDUAL DENTAL CARE PRODUCT FOR PREVENTING DEMINERALISATION 2020
  • Khug, Mikhael
  • Lisek, Dominikus Amadeus
RU2834399C1
CONTROLLED RELEASE THERAPEUTIC AGENTS CONTAINING PEPTIDES 2009
  • Berton Kevin
  • Ver Torsten
  • Tajs Tomas R.
  • Ehjub Mimun
RU2543327C2
GLUCAGON ANALOGUES, HAVING HIGH SOLUBILITY IN PHYSIOLOGICAL pH BUFFERS 2008
  • Dimarchi Richard D.
  • Dimarchi Marija
  • Chabenne Dzhozef
RU2477286C2
PROCESS FOR PREPARATION OF GLYCOPEPTIDE HAVING SIALYLATED SUGAR CHAIN, AND METHOD FOR PRODUCING SIALYL GLYCOASPARAGINE 2012
  • Kadzikhara Yasukhiro
  • Murakami Masumi
  • Isij Kadzuyuki
RU2586524C2
HEMOSTATIC COMPOSITIONS 2016
  • Zbozien Renata
  • Nichols Ben
RU2744694C2
DUAL GLP1/GIP OR TRIGONAL GLP1/GIP/GLUCAGON AGONISTS 2013
  • Khaak Torsten
  • Vagner Mikhael
  • Khenkel Bernd
  • Shtengelin Zigfrid
  • Efers Andreas
  • Lorents Martin
  • Lorents Katrin
RU2652783C2
METHOD OF PRODUCING PEPTIDE 2008
  • Kadzikhara Jasukhiro
  • Sakamoto Izumi
  • Nambu Juri
  • Fukae Kazukhiro
  • Asai Khiroaki
RU2478105C2
MOTILIN-LIKE PEPTIDE COMPOUND HAVING IMPARTED TRANSMUCOSAL ABSORBING ABILITY 2010
  • Sato Sejdzi
  • Khanada Takesi
  • Vakabajasi Naomi
  • Masuda Jutaka
  • Kharada Juriko
RU2540012C2

RU 2 740 185 C2

Authors

Suganuma, Yuya

Ojio, Tatsuya

Yokoi, Hidenori

Dates

2021-01-12Published

2015-12-10Filed